TGF-beta: A Deep Dive in Cancer Immunotherapy Targets

When:  May 26, 2021 from 14:00 to 16:00 (ET)

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "TGF-beta: A Deep Dive in Cancer Immunotherapy Targets" is the first seminar in the series.

Co-chairs
:

  • James L. Gulley, MD, PhD, FACP – National Cancer Institute
  • Shannon J. Turley, PhD – Genentech, Inc.

Faculty:

  • Mary Helen Barcellos-Hoff, PhD – University of California San Francisco
  • Ming O. Li, PhD – Memorial Sloan-Kettering Cancer Center
  • Dean Sheppard, MD – University of California San Francisco

Seminar agenda:

  • 2:00-2:05 pm ET: Welcome and Introductions
  • 2:05-3:20 pm ET: Faculty Presentations
  • 3:20-3:50 pm ET: Question and Answer Session
  • 3:50-4:00 pm ET: Closing Remarks

This webinar is supported, in part, by independent medical education grant funding from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, and Merck & Co., Inc.